CMT‐GlyRS mutants competed with VEGF‐A for binding to Nrp1, and heterozygosity for Nrp1 enhanced the peripheral neuropathy phenotype of GarsP278KY/+ mice. The gene discussed is NRP1; the disease is peripheral neuropathy.